MENU
ARGX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
argenx SE (ARGX) Ownership - Who owns argenx SE?
Argenx is a Dutch biopharmaceutical company focused on developing antibody-based therapies for rare autoimmune diseases... Show more
Industry: #Pharmaceuticals Other
Profile
Industry
Pharmaceuticals Other
Address
Laarderhoogtweg 25
Phone
+31 107038441
Employees
1148
Web
https://www.argenx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
36.83B
P/E Ratio
46.44
Total Cash
3.1B
Projected Growth
N/A
Total Debt
33.96M
Revenue
1.86B
Risk (Beta)
0.21
Dividend Yield
N/A
Total Cash/Share
50.87
Total Debt/Equity
N/A
Revenue/Share
33.60 USD as % of share price
Fundamentals
ARGX
Capitalization
36.8B
P/E Ratio
46.44
Risk (Beta)
0.21
Dividend Yield
N/A
Total Cash
3.1B
Total Cash/Share
50.87
Total Debt
34M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
33.60%
Revenue
1.86B
ROE
N/A
Book Value
4.26B
P/B Ratio
6.58
Cash Flow
N/A
Earnings
-0.7
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
7.12M
Current Ratio
8.53
Current Revenue Per Employee
499334.50
Dividends Per Share - Security
N/A
EBITDA
-60.47M
Float
N/A
Float - Current
N/A
Gross Income Margin
89.69
Revenue To Assets
-5.11
Shares Held By Institutions
46.1B
Shares Outstanding - Current
61M
Total Liabilities
534M
Total Volume MTD
N/A
Value
-1
Gain YTD
-5.096
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a manufacturer of antibody-based medicines
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
Laarderhoogtweg 25
Phone
+31 107038441
Employees
1148
Web
https://www.argenx.com